Beta Bionics (BBNX) Institutional Ownership $23.55 +0.26 (+1.12%) As of 09:47 AM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Beta Bionics (NASDAQ:BBNX)Number ofInstitutional Buyers(last 12 months)40TotalInstitutional Inflows(last 12 months)$239.22MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$6.38M Get BBNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Beta Bionics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data BBNX Institutional Buying and Selling by Quarter Beta Bionics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Soleus Capital Management L.P.3,820,158$55.62M3.7%+12.5%8.788% 8/15/2025 Holocene Advisors LP770,851$11.22M0.0%-30.4%1.773% 8/15/2025 Gilder Gagnon Howe & Co. LLC244,202$3.56M0.0%N/A0.562% 8/15/2025 Eventide Asset Management LLC4,932,351$71.83M1.3%+0.1%11.347% 8/15/2025 Bank of America Corp DE72,245$1.05M0.0%+17.4%0.166% 8/15/2025 Ameriprise Financial Inc.20,771$302K0.0%-61.6%0.048% 8/14/2025 Raymond James Financial Inc.216,349$3.15M0.0%N/A0.498% 8/14/2025 Soros Fund Management LLC25,000$364K0.0%-3.7%0.058% 8/14/2025 Quantinno Capital Management LP19,770$288K0.0%N/A0.045% 8/14/2025 The Manufacturers Life Insurance Company 23,558$343K0.0%+10.3%0.054% Get the Latest News and Ratings for BBNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 Divisadero Street Capital Management LP948,965$13.82M0.9%N/A2.183% 8/13/2025 Marshall Wace LLP614,965$8.95M0.0%-8.7%1.415% 8/13/2025 Walleye Capital LLC218,189$3.18M0.0%+47.3%0.502% 8/13/2025 Sands Capital Alternatives LLC3,570,113$51.98M10.2%+15.0%8.213% 8/12/2025 XTX Topco Ltd18,318$267K0.0%N/A0.042% 8/12/2025 Rhumbline Advisers18,439$268K0.0%+43.2%0.042% 8/12/2025 Legal & General Group Plc3,976$58K0.0%+197.4%0.009% 8/8/2025 Geode Capital Management LLC312,930$4.56M0.0%+2.3%0.720% 8/1/2025 Jennison Associates LLC59,185$862K0.0%-12.5%0.137% 7/29/2025 Values First Advisors Inc.42,563$620K0.3%+13.2%0.098% 7/25/2025 CWM LLC4,011$58K0.0%N/A0.009% 7/15/2025 Palumbo Wealth Management LLC29,579$431K0.1%N/A0.068% 6/27/2025 Goldman Sachs Group Inc.58,422$715K0.0%N/A0.135% 5/29/2025Rhumbline Advisers12,880$158K0.0%N/A0.030% 5/28/2025Strs Ohio2,400$29K0.0%N/A0.006% 5/16/2025Woodline Partners LP125,000$1.53M0.0%N/A0.288% 5/16/2025Goldman Sachs Group Inc.58,422$715K0.0%N/A0.135% 5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,772$95K0.0%N/A0.018% 5/16/2025Eventide Asset Management LLC4,928,019$60.31M1.2%N/A11.366% 5/16/2025Alyeska Investment Group L.P.75,000$918K0.0%N/A0.173% 5/15/2025RA Capital Management L.P.500,000$6.12M0.1%N/A1.153% 5/15/2025Braidwell LP140,000$1.71M0.1%N/A0.323% 5/15/2025Ghisallo Capital Management LLC50,000$612K0.1%N/A0.115% 5/15/2025Driehaus Capital Management LLC882,277$10.80M0.1%N/A2.035% 5/15/2025Omega Fund Management LLC1,988,287$24.34M14.4%N/A4.586% 5/14/2025Corebridge Financial Inc.6,485$79K0.0%N/A0.015% 5/14/2025MetLife Investment Management LLC8,370$102K0.0%N/A0.019% 5/14/2025Walleye Capital LLC148,105$1.81M0.0%N/A0.342% 5/14/2025Sands Capital Ventures LLC3,103,782$37.99M9.3%N/A7.159% 5/14/2025Wellington Management Group LLP3,901,599$47.35M0.0%N/A8.999% 5/13/2025Lord Abbett & CO. LLC228,160$2.79M0.0%N/A0.526% 5/12/2025Nuveen LLC17,044$209K0.0%N/A0.039% 5/12/2025Invesco Ltd.16,464$202K0.0%N/A0.038% 5/9/2025Deutsche Bank AG12,079$148K0.0%N/A0.028% 5/9/2025Charles Schwab Investment Management Inc.101,614$1.24M0.0%N/A0.234% 5/7/2025TD Asset Management Inc39,876$488K0.0%N/A0.092% 5/5/2025Jennison Associates LLC67,611$828K0.0%N/A0.156% 4/30/2025Values First Advisors Inc.37,585$457K0.3%N/A0.087% 4/29/2025Bank of New York Mellon Corp25,793$316K0.0%N/A0.060% 4/22/2025Evanson Asset Management LLC38,772$475K0.0%N/A0.089% 4/8/2025Rhumbline Advisers12,880$158K0.0%N/A0.030% (Data available from 1/1/2016 forward) BBNX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BBNX shares? During the previous two years, 44 institutional investors and hedge funds held shares of Beta Bionics. The most heavily invested institutionals were Eventide Asset Management LLC ($71.83M), Soleus Capital Management L.P. ($55.62M), Sands Capital Alternatives LLC ($51.98M), Wellington Management Group LLP ($47.35M), Sands Capital Ventures LLC ($37.99M), Omega Fund Management LLC ($24.34M), and Divisadero Street Capital Management LP ($13.82M).Learn more on Beta Bionics' institutional investors. Which institutional investors have been buying Beta Bionics' stock? Of the 40 institutional investors that purchased Beta Bionics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($4.93M), Wellington Management Group LLP ($3.90M), Sands Capital Ventures LLC ($3.10M), Omega Fund Management LLC ($1.99M), Divisadero Street Capital Management LP ($948.97K), Driehaus Capital Management LLC ($882.28K), and RA Capital Management L.P. ($500K). How much institutional buying is happening at Beta Bionics? Institutional investors have bought a total of 19,074,437 shares in the last 24 months. This purchase volume represents approximately $239.22M in transactions. Which of Beta Bionics' major shareholders have been selling company stock? The following institutional investors have sold Beta Bionics stock in the last 24 months: Holocene Advisors LP ($336.96K), Marshall Wace LLP ($58.69K), Ameriprise Financial Inc. ($33.25K), Jennison Associates LLC ($8.43K), and Soros Fund Management LLC ($968.00). How much institutional selling is happening at Beta Bionics? Institutional investors have sold a total of 438,302 shares in the last 24 months. This volume of shares sold represents approximately $6.38M in transactions. Related Companies TransMedics Group Institutional Ownership Envista Institutional Ownership Soleno Therapeutics Institutional Ownership LivaNova Institutional Ownership Warby Parker Institutional Ownership Liquidia Technologies Institutional Ownership Inspire Medical Systems Institutional Ownership LeMaitre Vascular Institutional Ownership PROCEPT BioRobotics Institutional Ownership Artivion Institutional Ownership This page (NASDAQ:BBNX) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
